Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CERO | Common Stock | Sale | -$148K | -1.24M | -5.47% | $0.12 | 21.4M | Dec 6, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
transaction | CERO | Common Stock | Sale | -$93.6K | -851K | -3.98% | $0.11 | 20.5M | Dec 9, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
transaction | CERO | Common Stock | Sale | -$141K | -1.57M | -7.65% | $0.09 | 19M | Dec 10, 2024 | By YK Bioventures Opportunities Fund I, L.P. | F1 |
Id | Content |
---|---|
F1 | Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein. |